Skip To Content

Quadron Deploys Extraction Processing Research Facility


June 21, 2017

Vancouver, BCQuadron Cannatech Corp. (CSE:QCC) (the “Company” or “Quadron”) announces the completion of its next generation extraction and processing facility which incorporates Quadron’s latest proprietary CO2extraction technology.

Rosy Mondin, President and CEO of Quadron commented, “The deployment of this advanced research and development facility provides Quadron with the necessary tools and environment required for the advancements of automated solutions and processes.  Such research is imperative to the continued development of Quadron’s intellectual property, and is highly complementary to the sale of our custom-branded accessories business.  We anticipate these two verticals to provide recurring revenues and rapidly grow in tandem in the second half of 2017 and beyond.”

Engaging in research to continuously update and modernize Quadron’s line of extraction equipment and methodologies gives Quadron a leading-edge advantage.  This on-going R&D will help generate new revenue opportunities and market growth for Quadron as its product and service offerings expand to a variety of markets and industries, and address the emerging needs of authorized cannabis industry participants, patients, growers, processors, and manufacturers.

Consumption data from legalized jurisdictions is trending away from dried cannabis to cannabis oil and oil-based products which are consumed in a variety of ways.  Delivery of this oil is done using different types of hardware (such as vapor pens) and other means of consumption (such as capsules).  Quadron, being a leader of innovation, automation and oil extraction of cannabis is well positioned to capture this growing mega trend of oil consumption in the cannabis industry.

The move towards extract-based products also supports public health policies that provide for safer and more discreet alternatives to combustion-based methods of cannabis consumption.

About Quadron Cannatech

Quadron focuses on ancillary equipment, products and services for the authorized cannabis industry, providing automated extraction and processing solutions, and sales of end user delivery solutions such as vape pens, capsules and other safer consumption solutions for patients.

For more information, visit:

On behalf of the Board of Directors of

For further information:
Rosy Mondin
President & CEO
(604) 346-8118

Investor Relations Contact:
Caleb Jeffries

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”.  Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company’s future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.


Stay Up To Date

Sign up to receive updates from our clients in the sectors that interest you. We don’t share your information with third parties and you can opt out at any time.
  • This field is for validation purposes and should be left unchanged.